Clinical trials
Phase 2 Ischemic Stroke trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shionogi | 2 |
| Bayer | 1 |
| Biogen | 1 |
| Bristol-Myers Squibb | 1 |
| GlaxoSmithKline | 1 |
| Healios K.K. | 1 |
| M's Science Corporation | 1 |
| ReNeuron Limited | 1 |
| Takeda | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 12 |
| Stroke | 5 |
| Antiphospholipid Syndrome | 1 |
| Brain Ischemia | 1 |
| Cerebral Infarction | 1 |
| Cerebrovascular Disorders | 1 |
| Hyperglycemia | 1 |
| Ischemic Attack, Transient | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Paresis | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.